Cargando…
Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma
BACKGROUND: The prognosis is poor for hepatocellular carcinoma (HCC), a tumor and cancer associated with inflammation that is common. New data showed that significant levels of KIAA1522 were expressed in HCC tissues and cell lines, suggesting that KIAA1522 may be a highly useful prognostic marker fo...
Autores principales: | Shi, Yongjie, Xiao, Qiwen, Huang, Sicong, Pan, Qimou, Jia, Hongyun, Zhou, Qiang, Wei, Jie, Kang, Jiale, Li, Zhe, Hu, Yingyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904920/ https://www.ncbi.nlm.nih.gov/pubmed/36761433 http://dx.doi.org/10.1155/2023/3538928 |
Ejemplares similares
-
High KIAA1522 expression predicts a poor prognosis in patients with hepatocellular carcinoma
por: Xu, Yongzheng, et al.
Publicado: (2020) -
KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer
por: Liu, Yi-Zhen, et al.
Publicado: (2016) -
The Prognostic Significance of KIAA1522 Expression in Non-Small-Cell Lung Cancer Patients
por: Özdede, Murat, et al.
Publicado: (2023) -
KIAA1522 Promotes the Progression of Hepatocellular Carcinoma via the Activation of the Wnt/β-Catenin Signaling Pathway
por: Jiang, Shunbin, et al.
Publicado: (2020) -
Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC
por: Jiang, Yu-Juan, et al.
Publicado: (2022)